Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model

Jae Young Hong, Sun Woong Kang, Jung Wook Kim, Seung Woo Suh, You Jin Ko, Jung Ho Park

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)

    Abstract

    Background aims: Heparin-conjugated fibrin (HCF) is a carrier for long-term release of bone morphogenetic protein-2 (BMP-2) and has been shown to promote bone formation in animal models. We performed an experimental study to determine the optimal dose of BMP-2 with an HCF carrier that promotes bone formation comparable to that of autograft while minimizing complications in spinal fusion. Methods: Twenty-four rabbits underwent posterolateral fusion of the L5-6 spinal segments. Different concentrations of HCF BMP-2 (1/10, 1/20, 1/30 or 1/40) were implanted in the spines of experimental rabbits, and autograft or INFUSE was implanted in the spines of control animals. Eight weeks after treatment, spinal fusion efficacy was evaluated by plain radiography, micro-computed tomography (micro-CT), mechanical testing and histomorphometry. Results: Similar to autograft, the 1/40 HCF BMP-2 showed significant bone formation on micro-CT and histomorphometry with mechanical stability. However, the other HCF BMP-2 concentrations did not show significant bone formation compared with autograft. Although conventional BMP-2 (INFUSE) led to higher bone formation and stability, it also led to excessive ectopic bone and fibrous tissue formation. Conclusions: This study suggests the optimal concentration of BMP-2 using HCF for spinal fusion, which may decrease the complications of high-dose conventional BMP-2.

    Original languageEnglish
    Pages (from-to)1441-1448
    Number of pages8
    JournalCytotherapy
    Volume16
    Issue number10
    DOIs
    Publication statusPublished - 2014 Oct 1

    Bibliographical note

    Funding Information:
    This work was supported by the Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ0099562014 ), Rural Development Administration, Republic of Korea .

    Publisher Copyright:
    © 2014 International Society for Cellular Therapy.

    Keywords

    • Autograft
    • BMP-2
    • Heparin-conjugated fibrin
    • Spinal fusion

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology
    • Oncology
    • Genetics(clinical)
    • Cell Biology
    • Cancer Research
    • Transplantation

    Fingerprint

    Dive into the research topics of 'Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model'. Together they form a unique fingerprint.

    Cite this